1 We now report 3-year overall survival outcomes in this trial.
2 We now report a combination of pharmacological, electrophysio
3 We now report a different approach where the nitrogen donor i
4 We now report a new Hmox1 reporter line that makes it possibl
5 We now report a novel genetically encoded fluorescent probe (
6 We now report a retrospective study of human biopsy samples u
7 We now report a sensing assay that is compatible with aqueous
8 We now report a structurally unrelated compound, Photoregulin
9 We now report comprehensive ribosome profiling of a yeast cel
10 We now report defined assembly intermediates on the path to m
11 We now report findings from a successful three-year field tri
12 We now report human bi-allelic P4HA1 mutations in a family wi
13 We now report pacemaker function of iPSC-CMs in a canine mode
14 We now report that activation of mGlu3 induces long-term depr
15 We now report that Akt3 constitutively suppresses macropinocy
16 We now report that CVB-infected cells trigger DRP1-mediated f
17 We now report that cytoplasmic DPPA3 is partially cleaved by
18 We now report that dynein stimulation in intestinal cells in
19 We now report that hyperglycaemia-induced repression of miR-3
20 We now report that ImmunoCloak interrupts antigen presentatio
21 We now report that in female rats, increased spinal dynorphin
22 We now report that increased expression of NKG2D ligands afte
23 We now report that knockdown of MAFB impairs the acquisition
24 We now report that lack of T. brucei RFT1 (TbRFT1) not only a
25 We now report that numbers of cerebral cortical and cerebella
26 We now report that PAR4 and P2Y12 heterodimer internalization
27 We now report that ShcD binds to active Ret, TrkA, and TrkB n
28 We now report that SMAP treatment inhibited the growth of KRA
29 We now report that STAT3 also binds the COL1A2 enhancer and i
30 We now report that the corA leader also controls two subseque
31 We now report that the HTCS BT0366 is phosphorylated in vivo
32 We now report that the recovery of both recipient MDSCs (P <
33 We now report that the Salmonella adaptor ClpS binds to the N
34 We now report that the same conformational TR-FRET based immu
35 We now report that they can both be generated easily and trap
36 We now report that, in male and female adult human subjects,
37 We now report the crystal structure of a full-length lipid A
38 We now report the crystal structure of AcrIIA4 in complex wit
39 We now report the development and characterization of a COBRA
40 We now report the development and technical validation of a r
41 We now report the development of a sporadic tauopathy model t
42 We now report the effects of the pro-attentional drug, d-amph
43 We now report the health-related quality of life (HRQOL) seco
44 We now report the histology-specific subgroup analysis of the
45 We now report the identification and the PIP requirements of
46 We now report the identification of FcgammaRIIIa-specific art
47 We now report the natural history of pneumonic tularemia in f
48 We now report the structure-guided optimization of this chemi
49 We now report the use of ammonium halides as HX surrogates to
50 We now report ZMPSTE24 is a virus-specific effector that rest